HNCs rely on flexible metabolic pathways to support growth and resist treatment. Their dependence on glucose and ability to shift to lipid and amino acid metabolism offer promising targets for therapy.
Bani-Ahmad et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: